We have prepared three distinct polyamino acid-based metal-organic frameworks (MOFs) with different chiralities and porosities using the same chemistry, by simply modifying the enantiomeric ratio of the chiral organic ligand used.
No takes yet. Share an insight, caveat, or question.
Burneo et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: